According to a report by journalnow on January 22, the US Food and Drug Administration (FDA) has rejected Bidi Vapor LLC's market application for the Bidi Stick Classic e-cigarette.
After the FDA issued a marketing denial order, Bidi vapour company has been prohibited from selling or distributing its product in the US market, otherwise it will face enforcement actions from the FDA. However, Bidi vapour company has the right to submit a new marketing application to the FDA.
According to the FDA's requirements, e-cigarette manufacturers must prove that their products not only serve as a reduced-risk alternative for adult smokers but also ensure that the transition to their products does not result in the illegal use of these products by individuals under the age of 21. However, the FDA believes that Bidi Vapor Company has failed to meet these evidentiary requirements.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
